Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Ability of Prediction of Fibrosis for ST-2 as a Non-invasive Marker in Chronic Hepatitis B

NCT01633554 is registered in ClinicalTrials.gov with Turkiye Yuksek Ihtisas Education and Research Hospital as lead sponsor.

NCT NCT01633554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01633554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Ability of Prediction of Fibrosis for ST-2 as a Non-invasive Marker in Chronic Hepatitis B
Lead sponsor
Turkiye Yuksek Ihtisas Education and Research Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2011
Completion date
September 30, 2012
Enrollment
95 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sequela of chronic liver disease